Investment framwork tanzania_cs-powerpoint
-
Upload
indonesia-aids-coalition -
Category
Health & Medicine
-
view
315 -
download
0
Transcript of Investment framwork tanzania_cs-powerpoint
!"#$%"&#'$()*$#)"+,-*$%.,/"0.,")1$"2$(3.#($")."!&45"
"
6.,$"7-89$"0.,")1$"6.#$:"%;)1;#"-"+,-*$%.,/".0"
51-,$<"2$(3.#(;=;8;):"
Resources available for HIV in low and middle income countries, 1986-2010
We have done a lot…
! >#3,$?$<$#)$<"(?-8$"93".0"@&7"3,$'$#A.#B"),$-)*$#)B"?-,$"-#<"
(933.,)"
! 4$?8;#$";#",-)$".0"#$%"@&7";#0$?A.#(";#"*-#:"?.9#),;$("
! 6.,$")1-#"CDC"*;88;.#"3$.38$".#"
!2E"
! 6;88;.#(".0".,31-#(",$?$;';#F"=-(;?"
$<9?-A.#B"1$-8)1B"(.?;-8"3,.)$?A.#"
But we can do better
5?-8$"93")."<-)$"F9;<$<"=:"-"G?.**.<;):"-33,.-?1H"
"! >#(:()$*-A?"3,;.,;A(-A.#"-#<";#'$()*$#)"%;)1"8;*;)$<"=-(;(";#"?.9#),:"$3;<$*;.8.F:"-#<"?.#)$I)"
! 2$(.9,?$("(3,$-<")1;#8:"-?,.(("*-#:"3-,-88$8";#)$,'$#A.#("
! +.?9(".#"<;(?,$)$";#)$,'$#A.#(",-)1$,")1-#".'$,-88",$(98)("8$-<;#F")."-"0,-F*$#)$<",$(3.#($"
New Investment Framework
SYNERGIES WITH DEVELOPMENT SECTORS Social protection; Education; Legal Reform; Gender equality; Poverty reduction; Gender-based violence; Health systems (incl. treatment of STIs, blood safety); Community systems; Employer practices.
CRITICAL ENABLERS
Social enablers • Political commitment &
advocacy • Laws, policies &
practices • Community mobilization • Stigma reduction • Mass media • Local responses, to
change risk environment
Programme enablers • Community-centered
design & delivery • Programme
communication • Management & incentives • Production & distribution • Research & innovation
Care & treatment
Male circumcision
Keeping people alive
BASIC PROGRAMME ACTIVITIES
Key populations
Children & mothers
Condoms
OBJECTIVES
Stopping new infections
Behaviour change
!
"
#!
#"
$!
$"
%!
%"
$!## $!#$ $!#% $!#& $!#" $!#' $!#( $!#) $!#* $!$!
Three investment scenarios Impact on the epidemic
>54"JK;88;.#(L"
M"NDO"
M"NDP"
M"QDO"
M"QDP"
M"PDO"
M"P" R$%"@&7"�$?A.#("
J*;88;.#(L"
K9(;#$(("-("9(9-8"M"NDO"
M"NDP"
M"QDO"
M"QDP"
M"PDO"
M"P" R$%"@&7"�$?A.#("
J*;88;.#(L"
!
"
#!
#"
$!
$"
%!
%"
$!## $!#$ $!#% $!#& $!#" $!#' $!#( $!#) $!#* $!$!
>54"JK;88;.#(L"
K9(;#$(("-("9(9-8"
&#'$()*$#)"0,-*$%.,/"
M"NDO"
M"NDP"
M"QDO"
M"QDP"
M"PDO"
M"P" R$%"@&7"�$?A.#("
J*;88;.#(L"
Three investment scenarios Impact on the epidemic
!
"
#!
#"
$!
$"
%!
%"
$!## $!#$ $!#% $!#& $!#" $!#' $!#( $!#) $!#* $!$!
>54"JK;88;.#(L"
2-3;<"(?-8$"93"
3,$';.9("3,.S$?A.#("
K9(;#$(("-("9(9-8"
&#'$()*$#)"0,-*$%.,/"
M"NDO"
M"NDP"
M"QDO"
M"QDP"
M"PDO"
M"P" R$%"@&7"�$?A.#("
J*;88;.#(L"
Three investment scenarios Impact on the epidemic
!
"
#!
#"
$!
$"
$!## $!#$ $!#% $!#& $!#" $!#' $!#( $!#) $!#* $!$!
>54"JK;88;.#(L"
E1$"#$%";#'$()*$#)"0,-*$%.,/"
+.?9(".#"%1-)"*-/$("-"<;T$,$#?$"
K-(;?"U,.F,-**$"
!?A';A$("
V,;A?-8"W#-=8$,("
5:#$,F;$("
!" #!" $!" %!" &!" '!" (!" )!" *!" +!"
#!!"
,'!! %'!-&++ $'!-%&+ $!!-$&+ #!!-#++ '!-++ .'! V4X"V.9#)"J?$88(Y*8L
V.'$,-F$
ART coverage in 2015 by CD4 count
!" #!" $!" %!" &!" '!" (!" )!" *!" +!"
#!!"
,'!! %'!-&++ $'!-%&+ $!!-$&+ #!!-#++ '!-++ .'! V4X"V.9#)"J?$88(Y*8L
V.'$,-F$
13.1 million (health)
CD4 350
15 million
T4P
Returns on investment of new investment framework (2011-2020)
Outcomes
Total infections averted More than 12 million
Infant infections averted 1.9 million
Deaths averted 7.4 million
Life years gained 29.4 million
New investment framework: the tipping point
R$%8:"$8;F;=8$"0.,"),$-)*$#)"
R$%8:";#0$?)$<"
New infections, behaviour change and treatment coverage in Botswana
Behaviour change
New infections and treatment coverage
Cost and economic returns 2011 to 2020
Cost/Returns Total additional investment (over 10 years) US$46.5 Billion
Future treatment need averted US$40 Billion
Life years gained US$1,060 per life year gained
Investment framework projections for new HIV infections
Optimized investment will lead to rapid declines in new HIV infections in many countries
V.**9#;):"*.=;8;Z-A.#"-((9*3A.#(";#")1$"
;#'$()*$#)"0,-*$%.,/""V.()"$#'$8.3$["?.**9#;):"*.=;8;(-A.#"?.*3.#$#)".0")1$"
?,;A?-8"$#-=8$,("""
"
////$!##//0!1%23/ //$!#'/0!1(/23// /$!$!/0#1!/23///!((9*3A.#(["
• 43567897:/5;<<=3>?@/58A85>?@//• >3567897:/5;<<=3>?@/976B>57/:7C>B76@///• 377:/D;6/67<=3768E;3/;D/5;<<=3>?@/83:/C8@/F;6G769//• 377:/D;6/?68>3>3HI/H=>:8357I/9=A76B>9>;3/• A86E5>A8E;3/;D/A7;AC7/C>B>3H/F>?J/K4L/
V.**9#;):"*.=;8;Z-A.#["*-/$("(?-8$"93"3.((;=8$""
• R9*=$,".0"3$.38$")$()$<")1,.9F1"?.**9#;):"*.=;8;Z-A.#""
/$!#!M/&(/<>CC>;3/NLOPQ/// /$!#'M/#!+/<>CC>;3///
• 5$,';?$"<$8;'$,:"?.()("J),$-)*$#)L""
/$!#!M/0#)+/A76/@786////$!$!M/0#$'/A76/@786/N0#)/>3/C;F/>35;<7/5;=3?6>79Q//
/
• 4,;';#F"?.()("<.%#["0$%$,".9)3-A$#)"';(;)(B"?.**9#;):"(933.,)"($,';?$"*.<-8;A$("
• K$\$,"@$-8)1"]9)?.*$("
V.**9#;):"*.=;8;Z-A.#[""
;#?,$-($("$T$?A'$#$(("• O;<<=3>?@/<;2>C>98E;3/>3567897:/K4L/?79E3H/68?79/D;=6-
D;C:/>3/P83R83>8I/S><282F7I/T;=?J/UD6>58/83:/PJ8>C83:1///• O;39>9?73?/5;3:;</=97/>3/A89?/#$/<;3?J9/&/E<79/J>HJ76/>3/
5;<<=3>E79/F>?J/H;;:/5;<<=3>?@/73H8H7<73?/NV73@8Q////• K@A;?J7E58C/5>65=<5>9>;3/<;:7C/VF8S=C=-W8?8C/M//
– 5;67/>3?76B73E;3M//$&!I!!!/>3D75E;39/8B76?7:/;B76/?73/@7869/– F>?J/7382C769M/&$!I!!!/>3D75E;39/8B76?7:I/F>?J/<;:79?/<86H>38C/>3567897/>3/5;9?9/
/
Investement framework allocation in 2015
E-#Z-#;-["-##9-8"#$%"@&7";#0$?A.#(B"NPQQMNPNP"
!/
$!!!!/
&!!!!/
(!!!!/
*!!!!/
#!!!!!/
#$!!!!/
#&!!!!/
#(!!!!/
$!##/ $!#$/ $!#%/ $!#&/ $!#'/ $!#(/ $!#)/ $!#*/ $!#+/ $!$!/
K-($8;#$"J=9(;#$(("-("9(9-8L"
&#'$()*$#)"+,-*$%.,/"
K-($8;#$"J=9(;#$(("-("9(9-8L"
&#'$()*$#)"+,-*$%.,/"
E-#Z-#;-["-##9-8"!&45"<$-)1(B"NPQQMNPNP"
!/
$!!!!/
&!!!!/
(!!!!/
*!!!!/
#!!!!!/
#$!!!!/
#&!!!!/
$!##/$!#$/$!#%/$!#&/$!#'/$!#(/$!#)/$!#*/$!#+/$!$!/
K-($8;#$"J=9(;#$(("-("9(9-8L"
&#'$()*$#)"+,-*$%.,/"
Resources available for HIV in low and middle income countries, globally, 2002-2010
Percentage of care and treatment expenditure from international sources
Few donors meet the development assistance targets
Net development assistance in 2001 as % of gross national income
Norway Luxembourg
Sweden Denmark
Netherlands Belgium
United Kingdom Finland Ireland France Spain
Switzerland Germany
Canada Austria
Australia Portugal
New Zealand United States
Japan Greece
Italy Korea
1.10% 1.09%
0.97% 0.90%
0.81%
0.50% 0.43% 0.41%
0.38% 0.33% 0.32% 0.32%
0.29% 0.26%
0.21% 0.20%
0.17% 0.15%
0.12%
0.64% 0.56%
0.55% 0.53%
0% 0.3% 0.5% 1% 1.2% 0.7%
Measuring national commitment to AIDS: the Domestic Investment Priority Index
SOURCE: UNAIDS expenditure data; WHO data on the burden disease; and economic data from the International Monetary Fund World Economic Outlook database
Economic growth in Africa, 1970–2010 Third-fastest growing region in the World
Three options for increasing domestic public HIV investment in Africa
Projected resource needs (in USD billion) Assumed increases of domestic contributions by BRICS and others within ability to pay (economic growth and towards Abudja targets)
LI 9.7
11.3 11.9
13.0 13.6 13.5 12.7 11.8 10.7 9.4 8.0
LMI
UMI
Developm
ent Assistance
Dom
estic financing XY4OT/
T;<7/Z=79E;39/
• [J8?/867/?J7/9?68?7H>5/;A73>3H9/D;6/8/37F/:>8C;H=7/86;=3:/7\5>735@]/
• U67/?J767/;2B>;=9/<>9-<8?5J79/27?F773/?J7/7A>:7<>5/83:/?J7/679A;397]/
• [J>5J/867/?J7/D85?;69/?J8?/<8G7/>?/:>\5=C?/?;/958C7/=A/289>5/A6;H68<<7/5;<A;373?9]//
• K;F/5;=C:/A86?3769/J7CA/>3/8AAC>58E;3/;D/?J7/4^/8AA6;85J/
The beginning of the end of AIDS is in our hands
Y785J>3H/A7;AC7/F>?J/976B>579M/_`8<AC79/D;6/$!#'/
V.'$,-F$"J3.398-A.#",$-?1$<L"
O;3:;<9/N:>95;6:83?/5;=AC79Q/ (!"/O;3:;<9/NJ>HJ/6>9G/A;AQ/ '!"/T7`/F;6G/ (!"/aTa/A6;H68<<79/ (!"/4bc/A6;H68<<79/ (!"/
6;88;.#"
K4L/?79E3H/ %$!/UYP/NOb&/%'!I/P&dQ/ ?;F86:9/#'/
O;9?/A76/A8E73?/A76/@786//NF7>HJ?7:/8B768H7/>3/cT0Q/
" " " " "NPQP " "NPQO " "NPNP"
/e82/N37F/A8E73?9Q/////// /#*!//// / /#$+/ / /)+///e82/N5;3?/A8E73?9Q//////// /#*!/ / /#$*/ / /)(///T76B>57/:7C>B76@/ / /#)(/ / /#&&/ / /##$///#9?/e>37/UYL9/ / / /#'' / /#&)/ / /')///$3:/e>37/UYL9// / /#()* / /+*& / /$+'//
P79E3H/83:/O;=397C>3H/O;B768H7/83:/5;9?/A76/A769;3/
!"#$%&'(%)*+',$%)"-,#'**'.%/,.%$'#$'.
01
021
031
041
051
061
071
081
091
0:1
1;1<12;
1<14;
1<16;
1<31;
1<51;
1<86; 6; 26
;36;
46;
56;
66;
76;
86;
96;
:6;
!"='(/>'
fTP/O;9?/U99=<AE;39/
V.()".0"6$)1-<.#$[""
• %%5/D;6/*!<H/>3/4683/?;/0$1!(/D;6/*!<H/>3/43:;379>8/
• U2;=?/cTb/#!!!/A76/A769;3/@786/
• g;>3H/:;F3/2@/$!"/>3/$!#'/83:/2@/J8CD/>3/$!$!/
• e>hC7/7B>:7357/D;6/7i75EB73799/• e>hC7/>3D;6<8E;3/;3/5;9?/• U9/8/A6;`@M/5;9?/F;6GAC857/A6;H68<9/N2@/$!#'I/'!"/5;B768H7/;D/?J7/#&*/<>CC>;3/7<AC;@779/>3/?J7/D;6<8C/975?;6/>3/5;=3?6>79/F>?J/H73768C>R7:/7A>:7<>59I/8B768H7/=3>?/5;9?/;D/cT0/+/A76/7<AC;@77/A76/@786Q//
X7J8B>;6/OJ83H7/d6;H68<<79/
• e>hC7/>3D;6<8E;3/;3/5;9?//
• O;=3?6@/67B>7F9/NcTb/#/?;/#&/A76/8:=C?/A;A=C8E;3Q//
• O;<<=3>?@/K78C?J/[;6G769/Nj/cTb/$/A76/8:=C?/A;A=C8E;3Q//
O;<<=3>?@/a;2>C>R8E;3/